Hi Tarvold..
Has this approvals timeline to implementation been noted before?
I wonder how many facilities are the 300 day ones?
And I saw they note again the cost - US$200 for 500ml as being economical in regards Xperience saving on the costs of continued infection and multiple return visits by those who succumb to continued infection.
I was trying to post a note to this the other day - wondering what the price tag is on the competitor products currently addressing the market.
It would be interesting to see the failure rate on current products too.
cheers
Ann: Investor Presentation, page-5
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $58.43M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.0¢ | $21.32K | 107.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20000 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| NXS (ASX) Chart |